Expand CBIO Menu
CBIO MENU

CBIO Latest Press Releases

-- February 5, 2026 --

Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 Globe Newswire 7:30 AM

-- January 30, 2026 --

Crescent Biopharma Announces Grants of Inducement Awards Globe Newswire 4:05 PM

-- January 5, 2026 --

Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors Globe Newswire 7:00 AM

-- December 18, 2025 --

Crescent Biopharma Announces Grants of Inducement Awards Globe Newswire 4:15 PM

-- December 4, 2025 --

Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors Globe Newswire 6:35 AM
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics Globe Newswire 6:30 AM

-- November 17, 2025 --

Crescent Biopharma Announces Grants of Inducement Awards Globe Newswire 4:15 PM

-- November 6, 2025 --

Crescent Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights Globe Newswire 7:30 AM

-- November 5, 2025 --

Crescent Biopharma to Present at November Investor Conferences Globe Newswire 7:30 AM

-- November 4, 2025 --

Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting Globe Newswire 9:05 AM
Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting Globe Newswire 9:05 AM
Market Data Delayed 15 Minutes